Addressing the high economic burden of the healthcare sector, prevention, early diagnosis and informed therapeutics are indispensable. Tests must be highly accurate and well integrated into medical management to avoid unnecessary treatment and tress to users. SmartHEALTH will address these complex issues by developing highly intelligent diagnostic technologies that are fully integrated into healthcare systems, optimising their impact in management and work practice. Driven by key targeted applications in cancer diagnostics (breast, cervical and colorectal), the project will deliver prototype systems with the aim of moving instrumentation from the laboratory, through to portable devices localised at the "point of care".
For further information, please visit:
http://www.smarthealthip.com
Project co-ordinator:
The University of Newcastle upon Tyne (UK)
Partners:
- University of Newcastle upon Tyne (UK),
- MiniFAB (Aust) Pty Ltd (AU),
- microfluidic ChipShop GmbH (DE),
- Institut für Mikrotechnik Mainz GmbH (DE),
- Zarlink Semiconductor (UK),
- Fraunhofer - Institut für BioMedizinische Technik (DE),
- Netherlands Organisation for Applied Scientific Research TNO (NL),
- Ikerlan Sociedad Cooperativa (ES),
- Fundación Gaiker (ES),
- IMEC (BE),
- Universitat Rovira i Virgili (ES),
- Wicht Technologie Consulting (DE),
- NEXUS Association (CH),
- Dublin City University (IRL),
- Centre Suisse dElectronique et de Microtechnique SA (CH),
- Università degli Studi di Trento (IT),
- TATAA Biocenter (SE),
- iXscient Ltd (UK),
- Fujirebio Diagnostics AB (SE),
- Olivetti I-Jet (IT),
- Forschungszentrum Karlsruhe GmbH (DE),
- Telecom Italia S.p.A. (IT),
- Charité Universitätsmedizin Campus Buch (DE),
- Frauenklinik der FSU Jena (DE),
- Fundación Vasca de Innovacion e Investigación Sanitarias (ES),
- SINTEF ICT (NO),
- Multi-D Analyses AB (SE)
Timetable: from 12/05 to 11/09
Total cost: 21.768.293
EC funding: 12.298.211
Instrument: IP
Project Identifier: IST-2004-2016817